| | | | |  | | By Erin Schumaker, Daniel Payne and Ruth Reader | | Presented by |  | | | | | | |  Biden's set a goal of reducing the cancer death by half over 25 years. | Getty Images | Federal agencies and private organizations are mobilizing to improve cancer screening access, the president's cancer cabinet announced Wednesday. Biden's health agencies are chipping in on the effort, as are agencies as varied as the Energy and Labor departments and the U.S. Fire Administration. Improving access to cancer screenings is a key part of the president's cancer moonshot initiative, which has the ambitious goal of reducing the cancer death rate by half over 25 years — and improving the lives of cancer patients and their caregivers. "It is important for every American to know that cancer screenings are lifesaving — early detection can make all the difference in beating the disease," President Joe Biden said in March. Why it matters: Americans missed nearly 10 million screenings during the pandemic, according to the White House, putting them at risk for later-stage cancer detection and worse health outcomes. The White House says that expanding screenings is a top moonshot priority. But it's noteworthy that the moonshot's latest actions on screenings lean heavily on federal agencies and private organizations at a time when Biden is struggling to secure more funding from Congress for his moonshot. Even so: Advocates of improved cancer care aren’t thrilled with Biden right now. That’s because his administration last week delayed an FDA rule to ban menthol cigarettes, POLITICO's Adam Cancryn and David Lim reported. At one point, officials had touted the prospective ban as evidence of progress the administration planned to make fighting cancer. Tobacco companies and some civil rights groups opposed the ban on the grounds that it could create a black market for menthol cigarettes, which would disproportionately affect minorities, and could lead to over-policing Black communities, where menthol smoking is more popular. The NAACP, however, is in favor of the ban. Others, including cancer groups and anti-smoking advocates like the American Cancer Society, Cancer Action Network and the Campaign for Tobacco-Free Kids weren't happy about the policy reversal. Rep. Robin Kelly (D-Ill.), chair of the Congressional Black Caucus’ Health Braintrust, said in a statement that she was "deeply disappointed" by the decision. "The FDA’s experts have been clear that menthol cigarettes are harmful to public health," Kelly said, adding, "This is a commonsense plan which could have saved hundreds of thousands of lives."
| | A message from The Michael J. Fox Foundation for Parkinson's Research: Help create a world without Parkinson's. Learn more. | | | | | | | THE GOLD STANDARD OF HEALTHCARE POLICY REPORTING & INTELLIGENCE: POLITICO has more than 500 journalists delivering unrivaled reporting and illuminating the policy and regulatory landscape for those who need to know what’s next. Throughout the election and the legislative and regulatory pushes that will follow, POLITICO Pro is indispensable to those who need to make informed decisions fast. The Pro platform dives deeper into critical and quickly evolving sectors and industries, like healthcare, equipping policymakers and those who shape legislation and regulation with essential news and intelligence from the world’s best politics and policy journalists.
Our newsroom is deeper, more experienced and better sourced than any other. Our healthcare reporting team—including Alice Miranda Ollstein, Megan Messerly and Robert King—is embedded with the market-moving legislative committees and agencies in Washington and across states, delivering unparalleled coverage of health policy and the healthcare industry. We bring subscribers inside the conversations that determine policy outcomes and the future of industries, providing insight that cannot be found anywhere else. Get the premier news and policy intelligence service, SUBSCRIBE TO POLITICO PRO TODAY. | | | | | | | | | 
New Zealand | Daniel Payne/POLITICO | This is where we explore the ideas and innovators shaping health care. Exercise showed benefits even for organs seemingly uninvolved in the exertion, like the liver, scientists with the Molecular Transducers of Physical Activity Consortium found in a study of rats. They think it could have implications for the treatment of human liver disease. Share any thoughts, news, tips and feedback with Carmen Paun at cpaun@politico.com, Daniel Payne at dpayne@politico.com, Ruth Reader at rreader@politico.com or Erin Schumaker at eschumaker@politico.com. Send tips securely through SecureDrop, Signal, Telegram or WhatsApp.
| | | | A message from The Michael J. Fox Foundation for Parkinson's Research:   | | | | | | |  AI could detect heart problems earlier, a new study found. | Getty Images | An artificial intelligence system that reviews electrocardiograms could help doctors decide which patients are at high risk of death — and intervene to improve their chances, according to new research in Nature Medicine. The paper reviewed the difference in care among 16,000 patients, half of whom had doctors who were aided by AI systems that flagged high risk of future mortality. Those warnings seemed to work, the researchers found. Use of the AI tool was associated with “a significant reduction” in all-cause mortality. How’s that? Among the patients whose doctors got AI-based alerts, 3.6 percent died within 90 days. But within the same time period for patients whose doctors didn’t get AI alerts, 4.3 percent died. The difference was starker among patients considered high-risk. Even so: Previous efforts to use AI to identify patients at risk haven’t worked well. Even if AI systems succeed in initial testing, health and AI experts say, their performance could shift over time, especially if the data on which they’re trained continues to change. That leaves health leaders waiting to see how government regulators will handle the technology — and what they will be responsible for — in determining its safety and efficacy.
| | A message from The Michael J. Fox Foundation for Parkinson's Research: We can see a future without Parkinson's. Help get us closer this Parkinson's Awareness Month. Learn more. | | | | | | | 
How AI will reshape a doctor's work remains an open question. | Joe Raedle/Getty Images | AI could help physicians translate care plans into a patient’s native language, add empathy to the clinical experience and allow for more remote care, but the technology also raises concerns about biased algorithms that could harm some people or amplify erroneous health information. Those were some of the themes scientists from Harvard, Yale, and Google discussed this week at the invitation of Harvard’s T.H. Chan School of Public Health. “You don't need to regulate the technology itself. You need to regulate how it's used,“ said Lucila Ohno-Machado, deputy dean for biomedical informatics at Yale University School of Medicine. Milind Tambe, director of Google Research’s “AI for Social Good” program, said he worries that AI could be misapplied in health care. AI has great promise, he said, but it’s not clear what its best use is. For this reason, Ohno-Machado said it could be important to enact laws around certain uses like deepfakes, or digital impersonations. Within the world of medical devices,“we need to have procedures and mechanisms to do sensible auditing,” said Andrew Beam, assistant professor of epidemiology at Harvard, citing a private-sector plan to create assurance labs that would vet AI tools. Why it matters: Health systems are adopting a growing array of those tools to help with everything from administrative tasks to assisting with diagnosis. They’re also considering how advanced AI and chatbots could play a role in triaging patients. Both federal and state legislators are considering how or whether they should regulate AI. Bias in algorithms has emerged as a key concern and lawmakers also are interested in creating rules that would require transparency into how AI programs work. What’s next? The private sector-led Coalition for Health AI, which is standing up the assurance labs, hopes to launch them this summer.
| | | | POLITICO IS BACK AT THE 2024 MILKEN GLOBAL CONFERENCE: POLITICO will again be your eyes and ears at the 27th Annual Milken Institute Global Conference in Los Angeles from May 5-8 with exclusive, daily, reporting in our Global Playbook newsletter. Suzanne Lynch will be on the ground covering the biggest moments, behind-the-scenes buzz and on-stage insights from global leaders in health, finance, tech, philanthropy and beyond. Get a front-row seat to where the most interesting minds and top global leaders confront the world’s most pressing and complex challenges — subscribe today. | | | | | | | | | Follow us on Twitter | | | | Follow us | | | | |
Comments
Post a Comment